CAHIC ZENAQ Animal Pharmaceutical Co., Ltd announced that it expects to receive CNY 82.72 million in funding from China Animal Husbandry Industry Co., Ltd., Pulike Biological Engineering, Inc.

CAHIC ZENAQ Animal Pharmaceutical Co., Ltd announced that it will receive CNY 82.72 million in an equity round of funding through capital increase on July 18, 2022. The transaction will include participation from existing investors China Animal Husbandry Industry Co., Ltd. for CNY 42.2307 million to hold 48.99% stake and Pulike Biological Engineering, Inc. for CNY 40.4893 million to hold 46.97% sake in the company. The shareholders of this capital increase subscribed for capital at the price of CNY 1 /registered capital, and the capital increase of CNY 82.72 million will be all included in the registered capital.

The transaction has been approved at the 29th meeting of the 4th board of directors and 15th meeting of the 4th supervisory committee of the company, and does not need to be submitted to the company's general meeting of shareholders for consideration.